Tucaxen 150 mg Tablet 

Tucaxen 150 mg Tablet contains the active ingredient Tucatinib, a tyrosine kinase inhibitor (TKI) specifically designed to treat HER2-positive breast cancer, particularly in advanced or metastatic stages. It represents a modern, targeted approach in oncology, offering patients a new level of precision and hope in their treatment journey.

🔬 Mechanism of Action:

Tucatinib works by selectively inhibiting the HER2 receptor, a protein that promotes the growth of cancer cells. Unlike broader inhibitors, Tucaxen targets HER2 specifically, helping to block cancer cell growth and spread while minimizing damage to healthy cells. It also crosses the blood-brain barrier, making it effective in treating brain metastases associated with HER2-positive cancers.

💊 Indications:

Tucaxen 150 mg is used in combination with trastuzumab and capecitabine for the treatment of:

• Adults with advanced or metastatic HER2-positive breast cancer, including those with brain metastases, who have received at least one prior anti-HER2-based regimen in the metastatic setting.

📋 Dosage & Administration:

• The recommended dose is 300 mg per day, usually taken as 150 mg twice daily (morning and evening).

• Can be taken with or without food.

• Should be used in combination with other HER2-targeted therapies, as directed by an oncologist.

• Always follow the doctor’s prescription strictly and never adjust the dosage without medical guidance.

⚠️ Contraindications & Warnings:

• Not recommended in patients with known hypersensitivity to tucatinib.

• Should be used with caution in patients with severe liver impairment.

• Women of childbearing potential should use effective contraception during and for at least 1 week after the last dose.

🔄 Possible Side Effects:

Common side effects include:

• Diarrhea

• Nausea, vomiting

• Fatigue

• Hand-foot syndrome (when used with capecitabine)

• Increased liver enzymes (ALT/AST)

Serious but rare side effects:

• Severe diarrhea or dehydration

• Liver toxicity

• Neutropenia or other blood-related effects

Routine liver function monitoring and complete blood counts are typically advised during treatment.

🧊 Storage:

• Store below 30°C in a dry place, away from moisture and light.

• Keep out of reach of children.

🌟 Why Choose Tucaxen 150 mg?

• Targeted cancer therapy that precisely attacks HER2-positive cells.

• Effective even in brain metastases — a major advancement over traditional therapies.

• Backed by clinical trials and approved globally for advanced HER2-positive breast cancer management.

• Enhances overall survival and progression-free survival when used as part of a combination therapy.

💡 Summary:

Tucaxen 150 mg Tablet is a breakthrough targeted therapy bringing new hope to patients battling HER2-positive metastatic breast cancer. With its precision mechanism, powerful combination potential, and proven clinical outcomes, Tucaxen helps you fight cancer with clarity and confidence.